Company: NCEL
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026428
Chunk: 788

Company: NewcelX Ltd.
Filing Date: 2025-03-31
Form: F-4/A
Chunk 788
---
 |    (158,071 | ) |     |      |     (50,791 | ) |
| Total shareholders’ equity (deficit)                                                                                                                       |     |              |  (8,833,563 | ) |     |      |   3,280,839 |   |
| Total liabilities and shareholders’ equity/(deficit)                                                                                                       |     | $            |   1,846,641 |   |     | $    |   9,276,643 |   |

The accompanying notes are an integral part of these financial statements.

Annex F-118

NLS PHARMACEUTICS LTD.
STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

| Operating expenses:                                                                          |     | For the Years Ended December 31, 
 2023                             |             |   |     | 2022 |             |   |     | 2021 |             |   |
|:---------------------------------------------------------------------------------------------|:----|:---------------------------------|------------:|:--|:----|:-----|------------:|:--|:----|:-----|------------:|:--|
| Research and development                                                                     |     | $                                |   5,908,288 |   |     | $    |   8,976,643 |   |     | $    |   5,919,452 |   |
| General and administrative                                                                   |     |                                  |   5,898,775 |   |     |      |   6,505,721 |   |     |      |   5,941,169 |   |
| Total operating expenses                                                                     |     |                                  |  11,807,063 |   |     |      |  15,482,364 |   |     |      |  11,860,621 |   |
| Operating loss                                                                               |     |                                  | (11,807,063 | ) |     |      | (15,482,364 | ) |     |      | (11,860,621 | ) |
| Other income (expense), net                                                                  |     |                                  |    (219,812 | ) |     |      |      10,045 |   |     |      |     (17,323 | ) |
| Interest expense                                                                             |     |                                  |    (119,920 | ) |     |      |     (95,211 | ) |     |      |     (48,100 | ) |
| Interest